Delivery Order SPE2DB22D1202-SPE2DB25FVLF1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- This delivery order, awarded September 11, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of methylergonovine 0.2 mg tablets in quantities of 28 units. The contract is valued at $7,605.24 with a firm fixed price structure and no set-aside designation, indicating competitive award status. Performance will be executed from the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 12, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $1,555.82 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Methylergon 0.2mg in a 12-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,142.49 and has an ultimate completion date of July 22, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were utilized for this award,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a $2,393.28 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract utilizes firm fixed pricing with an ultimate completion date of September 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,550 units of the medication Methylergonovine 0.2 mg Tablet. The firm-fixed-price contract, valued at $4,134.76, has an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLF1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylergonovine 0.2 mg tablets in unit dose packages of 20, with a ceiling value of $11,136.19. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle supports the Defense Logistics Agency's pharmaceutical supply mission by enabling the delivery of a comprehensive range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement requirements through the DLA Medical Supply Chain, serving critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/12/25 |